Molecular predictors of outcome with gefitinib and docetaxel in previously treated non-small-cell lung cancer: data from the randomized phase III INTEREST trial - Douillard, Jean-Yves; Shepherd, Frances A.; Hirsh, Vera; Mok, Tony; Socinski, Mark A.; Gervais, Radj; Liao, Mei-Lin; Bischoff, Helge; Reck, Martin; Sellers, Mark V.; Watkins, Claire L.; Speake, Georgina; et al. (Journal of clinical oncology, 2010)
Published online ahead of print at www.jco.org on December 28, 2009